Correlation Between BioMark Diagnostics and Spectral Med

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioMark Diagnostics and Spectral Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioMark Diagnostics and Spectral Med into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioMark Diagnostics and Spectral Med, you can compare the effects of market volatilities on BioMark Diagnostics and Spectral Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioMark Diagnostics with a short position of Spectral Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioMark Diagnostics and Spectral Med.

Diversification Opportunities for BioMark Diagnostics and Spectral Med

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between BioMark and Spectral is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding BioMark Diagnostics and Spectral Med in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spectral Med and BioMark Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioMark Diagnostics are associated (or correlated) with Spectral Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spectral Med has no effect on the direction of BioMark Diagnostics i.e., BioMark Diagnostics and Spectral Med go up and down completely randomly.

Pair Corralation between BioMark Diagnostics and Spectral Med

Assuming the 90 days horizon BioMark Diagnostics is expected to generate 3.36 times less return on investment than Spectral Med. But when comparing it to its historical volatility, BioMark Diagnostics is 1.19 times less risky than Spectral Med. It trades about 0.09 of its potential returns per unit of risk. Spectral Med is currently generating about 0.26 of returns per unit of risk over similar time horizon. If you would invest  32.00  in Spectral Med on October 24, 2024 and sell it today you would earn a total of  10.00  from holding Spectral Med or generate 31.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy90.48%
ValuesDaily Returns

BioMark Diagnostics  vs.  Spectral Med

 Performance 
       Timeline  
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Spectral Med 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Spectral Med are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Spectral Med may actually be approaching a critical reversion point that can send shares even higher in February 2025.

BioMark Diagnostics and Spectral Med Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioMark Diagnostics and Spectral Med

The main advantage of trading using opposite BioMark Diagnostics and Spectral Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioMark Diagnostics position performs unexpectedly, Spectral Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will offset losses from the drop in Spectral Med's long position.
The idea behind BioMark Diagnostics and Spectral Med pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
CEOs Directory
Screen CEOs from public companies around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges